• Michael Conte, MD, Chair
• Andrew Bradbury, MD
• Patrick Geraghty, MD
• Gregory Moneta, MD
• Mark Nehler, MD
• Richard Powell, MD
• Sarah Murphy, Staff Liaison

Scope of Work

• Publish objective performance goals (OPG) for new technology in the area of critical limb ischemia (CLI), in cooperation with FDA

2011-12 Charges

• Complete follow up publication (requested by FDA) outlining methodology for sliding-scale OPG
• Host CLI OPG stakeholders meeting  (investigators, industry and FDA) to encourage broad adoption of the recommendations for CLI trial design, facilitate data sharing between investigator groups and contribute to the validation and periodic refinement of the OPG

Updated July 2011